NeuroServe

Neuroservice is a leading contract research organization (CRO) specializing in in vitro and in vivo electrophysiology for central nervous system (CNS) and pain drug discovery. The company provides specialized services to pharmaceutical and biotech firms to evaluate the effects of compounds on neuronal circuits, ion channels, and synaptic plasticity. Utilizing advanced technologies such as Multi-Electrode Array (MEA) and automated patch-clamp, Neuroservice supports lead optimization, mechanism of action studies, and safety pharmacology. With facilities in France and the United States, the company plays a critical role in accelerating the development of therapies for neurological and psychiatric disorders.